Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc. GILD gained following the earnings beat and upbeat guidance for 2025, ...

Hyderabad's commercial real estate market booming, driven by technology sector, skilled talent pool, and growing Global Capability Centers.

According to a report by CBRE South Asia Pvt Ltd and HYSEA, the city's office stock has more than tripled since 2014, ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...

Diversifying investments with sector ETFs can reduce risks and enhance returns. Sector ETFs simplify targeted investments in different market areas, like tech or healthcare. Consider fund families ...

HONG KONG: If investors in China's biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd struck last month with Seattle-based Seagen ...

Given the complexity of this market sector, the biotech space can be tough to understand. Below we’ll break down biotech stocks and help you decide if you should invest in them. Biotech stocks ...